TRANDATE

This brand name is authorized in Austria, Australia, Canada, Cyprus, Estonia, Spain, France, Hong Kong, Ireland, Israel, Japan, Malta, Netherlands, New Zealand, Singapore, United Kingdom, South Africa

Active ingredients

The drug TRANDATE contains one active pharmaceutical ingredient (API):

1 Labetalol UNII 1GEV3BAW9J - LABETALOL HYDROCHLORIDE

Labetalol lowers the blood pressure by blocking peripheral arteriolar alphaadrenoceptors thus reducing peripheral resistance, and by concurrent betablockade, protects the heart from reflex sympathetic drive that would otherwise occur. Read about Labetalol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TRANDATE Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C07AG01	Labetalol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AG Alpha and beta blocking agents
Discover more medicines within C07AG01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1566K, 1567L
Country: CA	Health Products and Food Branch	Identifier(s): 02106272, 02106280
Country: EE	Ravimiamet	Identifier(s): 1007312, 1007828, 1680498
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 54527, 54528, 55318
Country: FR	Base de données publique des médicaments	Identifier(s): 60558554, 65193337
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 13901, 13902, 13930, 13933, 13972, 21622
Country: HK	Department of Health Drug Office	Identifier(s): 02799, 02800, 02802, 57922
Country: IE	Health Products Regulatory Authority	Identifier(s): 69787, 69795, 69809, 69817, 69833, 69841
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 285, 286, 4348
Country: JP	医薬品医療機器総合機構	Identifier(s): 2149009F1030, 2149009F2037
Country: MT	Medicines Authority	Identifier(s): AA565/04502, AA565/04503, AA729/12804, AA729/12805, AA770/14401
Country: NL	Z-Index G-Standaard	Identifier(s): 12303968
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 15024
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 20892, 20893, 2418
Country: SG	Health Sciences Authority	Identifier(s): 02281P
Country: ZA	Health Products Regulatory Authority	Identifier(s): J/7.1.3/52, J/7.1.3/54